Is Uniqure NV halal to invest in?

According to Musaffa's Shariah screening methodology, Uniqure NV (QURE) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Uniqure NV a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Uniqure NV using these criteria to determine its compliance status.

Can Muslims buy shares of Uniqure NV?

Muslim investors may consider investing in Uniqure NV if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Uniqure NV classified as NOT HALAL?

Musaffa determines the Shariah status of Uniqure NV by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Uniqure NV updated?

The Shariah compliance status of Uniqure NV may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Uniqure NV become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Uniqure NV?

You can check the latest Shariah compliance status of Uniqure NV on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

QURE Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 12, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Uniqure NV (QURE)

Based on 20 analysts giving stock ratings to Uniqure NV in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Uniqure NV. Stock Analysis QURE

United States Health Care Small Cap Report: 2025 Annual

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. The company employs 221 full-time employees The company went IPO on 2014-02-05. The company seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. The company develops, both internally and through partnerships, a pipeline of gene therapies. The company produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.

Key Statistics of Uniqure NV (QURE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$26.37$27.74

Today's Open

$27.40

Volume

1.45M

P/E Ratio (TTM)

52 Week Range

$8.73$71.50

Market Cap

1.30B

Avg. Volume

2.04M

Dividend Yield

Financial Metrics & Statements of Uniqure NV (QURE)

FAQ's for Uniqure NV (QURE)

According to Musaffa’s Shariah screening methodology, Uniqure NV (QURE) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.